COYA
Price
$6.25
Change
+$0.16 (+2.63%)
Updated
Dec 11 closing price
Capitalization
130.78M
Intraday BUY SELL Signals
NTLA
Price
$9.22
Change
-$0.33 (-3.46%)
Updated
Dec 12, 01:23 PM (EDT)
Capitalization
1.11B
69 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COYA vs NTLA

Header iconCOYA vs NTLA Comparison
Open Charts COYA vs NTLABanner chart's image
Coya Therapeutics
Price$6.25
Change+$0.16 (+2.63%)
Volume$245.28K
Capitalization130.78M
Intellia Therapeutics
Price$9.22
Change-$0.33 (-3.46%)
Volume$1.24K
Capitalization1.11B
COYA vs NTLA Comparison Chart in %
View a ticker or compare two or three
VS
COYA vs. NTLA commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a StrongBuy and NTLA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (COYA: $6.25 vs. NTLA: $9.55)
Brand notoriety: COYA and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 105% vs. NTLA: 38%
Market capitalization -- COYA: $130.78M vs. NTLA: $1.11B
COYA [@Biotechnology] is valued at $130.78M. NTLA’s [@Biotechnology] market capitalization is $1.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • COYA’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, both COYA and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 6 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • COYA’s TA Score: 6 bullish, 4 bearish.
  • NTLA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, COYA is a better buy in the short-term than NTLA.

Price Growth

COYA (@Biotechnology) experienced а +4.17% price change this week, while NTLA (@Biotechnology) price change was -1.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.31%. For the same industry, the average monthly price growth was +4.75%, and the average quarterly price growth was +65.86%.

Reported Earning Dates

NTLA is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+1.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.11B) has a higher market cap than COYA($131M). COYA YTD gains are higher at: 9.075 vs. NTLA (-18.096). COYA has higher annual earnings (EBITDA): -22.59M vs. NTLA (-501.87M). NTLA has more cash in the bank: 460M vs. COYA (29.8M). NTLA has higher revenues than COYA: NTLA (52.9M) vs COYA (423K).
COYANTLACOYA / NTLA
Capitalization131M1.11B12%
EBITDA-22.59M-501.87M5%
Gain YTD9.075-18.096-50%
P/E RatioN/AN/A-
Revenue423K52.9M1%
Total Cash29.8M460M6%
Total DebtN/A103M-
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COYANTLA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 26 days ago
86%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
COYA
Daily Signal:
Gain/Loss:
NTLA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SMVSX31.900.24
+0.76%
Invesco Small Cap Value R6
WFICX14.910.11
+0.74%
North Star Small Cap Value Institutional
MLPEX7.510.03
+0.40%
Invesco SteelPath MLP Select 40 C
SAMKX42.120.14
+0.33%
SA US Core Market
MSPRX24.98N/A
N/A
Morgan Stanley Inst Advantage C

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with GANX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then GANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
+2.63%
GANX - COYA
42%
Loosely correlated
-1.67%
KNSA - COYA
42%
Loosely correlated
+1.15%
ATXS - COYA
36%
Loosely correlated
-0.46%
IRON - COYA
33%
Loosely correlated
+0.81%
BMRN - COYA
33%
Poorly correlated
-1.32%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+1.92%
VCYT - NTLA
69%
Closely correlated
-2.56%
BEAM - NTLA
62%
Loosely correlated
+0.40%
CRSP - NTLA
60%
Loosely correlated
+0.87%
AXON - NTLA
55%
Loosely correlated
+2.22%
CDXS - NTLA
49%
Loosely correlated
-6.04%
More